US health authorities approve updated COVID-19 vaccines for fall 2026

Regulatory approval has been granted for updated COVID-19 vaccines targeting high-risk groups, including individuals aged 65 and older and those with underlying health conditions. While off-label access for the general population remains a possibility, the policy focuses on targeted immunization to mitigate seasonal transmission risks.